Estudio de la eficacia y la seguridad de MK-5475 en participantes con hipertensión arterial pulmonar
This is a two-part (Phase 2/Phase 3) study of MK-5475, an inhaled soluble guanylate cyclase stimulator, in participants with pulmonary arterial hypertension (PAH). The first part (Phase 2) will assess three